Skip to main content
Caplight Logo









Micregen

Micregen

Private
ReadingHealthcare & Life Scienceshttps://micregen.com

Last Round

VC Round

Apr 1, 2021

Est. Valuation

$124.61M

Total Funding Raised

$1.96M

Company Overview

Micregen operates in Healthcare & Life Sciences and is based in Reading. Its latest recorded funding round was a VC Round in April 2021.

Micregen is a biotechnology company that develops stem cell-derived secretome therapeutics for regenerative medicine.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Micregen Comparables

Compare Micregen with similar companies based on industry and business-model similarity.

Micregen comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Secretome Therapeutics
82%
Immunis, Inc.
81%
Noveome Biotherapeutics
81%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Micregen Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundApr 1, 2021
SeedApr 1, 2020
SeedFeb 1, 2017
SeedSep 28, 2016
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Micregen Investors

Notable investors and investment history

Micregen investors
InvestorRounds
Pitalia CapitalVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 16, 2024

    Grew 150% QoQ, from 2 to 5 employees.

  • Sep 28, 2016

    $1.43M raised in Seed funding.

Book a demo to see all signals

For institutional investors. Book with your work email.

Micregen Filings

Explore SEC and related filing metadata, where available.

Micregen filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Micregen's valuation, stock price, and market status.

Is Micregen a public or private company?

Micregen is a private company.

What is the current stock price of Micregen?

Micregen is a private company, so its shares have no public market price. Caplight tracks Micregen's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Micregen worth (valuation)?

Micregen's valuation is estimated at $124.6M based on funding round data.

Can I buy Micregen stock?

Micregen shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Micregen's last funding round?

Micregen's most recent funding round was VC Round on April 1, 2021.

Who are the main investors in Micregen?

Key investors in Micregen include Pitalia Capital.

Will Micregen IPO soon?

No public IPO plans have been announced for Micregen.

How can I track Micregen secondary market activity?

Caplight tracks bids, offers, and trades in Micregen's shares on secondary markets.

Firmographic Details

HeadquartersReading
Employee Range5
Year Founded2015
Last FundingApr 1, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?